• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇在预防和治疗支气管肺发育不良婴儿中的应用:第一部分:全身皮质类固醇。

Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. systemic corticosteroids.

机构信息

Department of Pediatrics, Faculty of Medicine and Albert Szent-Györgyi Health Center, University of Szeged, Szeged, Hungary.

Neonatal Intensive Care Unit, Department of Woman's and Child's Health, Padova University Hospital, Padova, Italy.

出版信息

Pediatr Pulmonol. 2022 Mar;57(3):600-608. doi: 10.1002/ppul.25805. Epub 2022 Jan 12.

DOI:10.1002/ppul.25805
PMID:34964559
Abstract

Bronchopulmonary dysplasia (BPD) is the most significant respiratory complication of prematurity, and its consequences last from birth into adulthood. Unfortunately, the dramatic improvements in the management of premature infants have not led to a decreased incidence of BPD, or to breakthroughs in treatments offered for this long-lasting chronic respiratory disorder. Over recent decades the pathological picture of BPD has changed from inflammation, interstitial fibrosis and emphysema attributed to volu-, barotrauma and oxygen toxicity to larger, simplified alveoli and dysmorphic vessels related to arrested alveolarization and vasculogenesis with inflammation maintaining a central role. Corticosteroids (CSs) play a key role in the development of respiratory epithelial cells and lung maturation. These potent anti-inflammatory agents have long been used for the prevention and treatment of BPD; however, the risk/benefit ratio of their use remains unresolved. CSs administered antenatally have contributed to reduce mortality and respiratory distress syndrome, no such effect on BPD reduction has been observed. Postnatal systemic CSs reduced the rate and severity of BPD, yet their long-term neurodevelopmental and respiratory consequences markedly limit routine administration. This is the first in a two-part State-of-the-Art series that reviews the latest relevant clinical trials investigating the short-term and long-term effects of CSs in the prevention and treatment of BPD.

摘要

支气管肺发育不良(BPD)是早产儿最严重的呼吸系统并发症,其后果从出生持续到成年。不幸的是,早产儿管理的显著改善并未导致 BPD 发病率降低,也未在这种长期慢性呼吸系统疾病的治疗方面取得突破。近几十年来,BPD 的病理表现已从归因于容积、气压伤和氧毒性的炎症、间质纤维化和肺气肿转变为与肺泡化和血管生成停滞相关的更大、更简单的肺泡和畸形血管,炎症仍起着核心作用。皮质类固醇(CSs)在呼吸上皮细胞和肺成熟中发挥着关键作用。这些强效抗炎药长期以来一直用于预防和治疗 BPD;然而,其使用的风险/收益比仍未得到解决。产前使用 CS 有助于降低死亡率和呼吸窘迫综合征,但对降低 BPD 没有观察到这种作用。全身用 CS 可降低 BPD 的发生率和严重程度,但它们对神经发育和呼吸系统的长期影响显著限制了常规应用。这是两部分最新临床研究综述系列的第一部分,该综述回顾了 CS 在预防和治疗 BPD 方面的短期和长期效果的最新相关临床试验。

相似文献

1
Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. systemic corticosteroids.皮质类固醇在预防和治疗支气管肺发育不良婴儿中的应用:第一部分:全身皮质类固醇。
Pediatr Pulmonol. 2022 Mar;57(3):600-608. doi: 10.1002/ppul.25805. Epub 2022 Jan 12.
2
Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.皮质类固醇在预防和治疗支气管肺发育不良婴儿中的应用:第二部分。单独使用吸入性皮质类固醇或与表面活性剂联合使用。
Pediatr Pulmonol. 2022 Apr;57(4):787-795. doi: 10.1002/ppul.25808. Epub 2022 Jan 12.
3
[The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].[早产儿使用产后皮质类固醇疗法预防或治疗支气管肺发育不良:现状与建议]
Arch Pediatr. 2010 Oct;17(10):1480-7. doi: 10.1016/j.arcped.2010.07.013. Epub 2010 Sep 22.
4
Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.早期(<8天)全身性产后使用皮质类固醇预防早产儿支气管肺发育不良
Cochrane Database Syst Rev. 2017 Oct 24;10(10):CD001146. doi: 10.1002/14651858.CD001146.pub5.
5
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.吸入或滴注类固醇用于预防支气管肺发育不良。
Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5.
6
Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.晚期(≥7天)吸入性皮质类固醇用于降低早产儿支气管肺发育不良的发生率
Cochrane Database Syst Rev. 2012 Apr 18(4):CD002311. doi: 10.1002/14651858.CD002311.pub3.
7
Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.关于产后皮质类固醇预防或治疗支气管肺发育不良的更新。
Am J Perinatol. 2019 Jul;36(S 02):S58-S62. doi: 10.1055/s-0039-1691802. Epub 2019 Jun 25.
8
Postnatal Corticosteroids To Prevent Bronchopulmonary Dysplasia.产后皮质类固醇预防支气管肺发育不良。
Neoreviews. 2023 Nov 1;24(11):e691-e703. doi: 10.1542/neo.24-11-e691.
9
Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.晚期(>7天)全身性产后皮质类固醇用于预防早产儿支气管肺发育不良
Cochrane Database Syst Rev. 2017 Oct 24;10(10):CD001145. doi: 10.1002/14651858.CD001145.pub4.
10
Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.新生儿后程糖皮质激素预防或治疗支气管肺发育不良。
Neonatology. 2021;118(2):244-251. doi: 10.1159/000515950. Epub 2021 May 11.

引用本文的文献

1
Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress.吸入性和全身性类固醇用于支气管肺发育不良:针对炎症和氧化应激
Antioxidants (Basel). 2025 Jul 16;14(7):869. doi: 10.3390/antiox14070869.
2
An updated review on systemic glucocorticoids in the prevention and treatment of bronchopulmonary dysplasia.关于全身用糖皮质激素预防和治疗支气管肺发育不良的最新综述。
Pediatr Discov. 2023 Jun 12;1(1):e6. doi: 10.1002/pdi3.6. eCollection 2023 Jun.
3
Prevention of Inflammatory Disorders in the Preterm Neonate: An Update with a Special Focus on Bronchopulmonary Dysplasia.
预防早产儿炎症性疾病:特别关注支气管肺发育不良的更新。
Neonatology. 2024;121(5):636-645. doi: 10.1159/000539303. Epub 2024 Jun 13.
4
Blood pressure in preterm infants with bronchopulmonary dysplasia in the first three months of life.支气管肺发育不良早产儿生命最初三个月的血压。
Pediatr Nephrol. 2024 Aug;39(8):2475-2481. doi: 10.1007/s00467-024-06354-0. Epub 2024 Mar 27.